LONG-TERM SAFETY OF FILGOTINIB IN PATIENTS WITH PSA: WEEK 52 SAFETY DATA FROM A PHASE 2 OPENLABEL EXTENSION STUDY

被引:0
|
作者
Coates, Laura [1 ]
Mease, Philip [2 ,3 ]
Gladman, Dafna [4 ]
Van den Bosch, Filip [5 ]
Rychlewska-Hanczewska, Anna [6 ]
Tasset, Chantal [7 ]
Meuleners, Luc [8 ]
Trivedi, Mona [9 ]
Guo, Ying [9 ]
Besuyen, Robin [7 ]
Helliwell, Philip [10 ]
机构
[1] Univ Oxford, Rheumatol, Oxford, England
[2] Swedish Med Ctr, Rheumatol, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Toronto, Rheumatol, Toronto, ON, Canada
[5] Univ Ghent, Rheumatol, Ghent, Belgium
[6] Ai Centrum Med Sp Zoo Spk, Rheumatol, Poznan, Poland
[7] Galapagos NV, Rheumatol, Mechelen, Belgium
[8] Galapagos NV, Biostat, Mechelen, Belgium
[9] Gilead Sci, Rheumatol, Foster City, CA USA
[10] Leeds Inst Rheumat & Musculoskeletal Med, Rheumatol, Leeds, W Yorkshire, England
来源
RHEUMATOLOGY | 2020年 / 59卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P219
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Gao, Jingjing
    Besuyen, Robin
    Helliwell, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Gladman, Dafna
    Coates, Laura
    Mease, Philip
    van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067
  • [3] Safety of Filgotinib in Patients with RA: Laboratory Analysis Results from a Long-Term Extension Study
    Buch, Maya
    Galloway, James
    Favalli, Ennio Giulio
    Constantin, Arnaud
    Durez, Patrick
    Van Hoek, Paul
    Watson, Christopher
    Stiers, Pieter-Jan
    Rajendran, Vijay
    Van Beneden, Katrien
    Takeuchi, Tsutomu
    Combe, Bernard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 535 - 538
  • [4] Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study
    Genovese, Mark C.
    Kavanaugh, Arthur
    Winthrop, Kevin
    Greenwald, Maria
    Ponce, Lucia
    Enriquez Sosa, Favio
    Stanislavchuk, Mykola
    Mazur, Minodora
    Spindler, Alberto
    Cseuz, Regina
    Nikulenkova, Natalya
    Glowacka-Kulesz, Maria
    Szombati, Istvan
    Dudek, Anna
    Mozaffarian, Neelufar
    Greer, Joy
    Ding, Xiao
    Harrison, Pille
    Van der Aa, Annegret
    Westhovens, Rene
    Alten, Rieke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] LONG TERM SAFETY OF FILGOTINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: WEEK 108 DATA FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Westhovens, R.
    Alten, R.
    Winthrop, K.
    Greenwald, M.
    Ponce, L.
    Enriquez-Sosa, F.
    Stanislavchuk, M.
    Mazur, M.
    Spindler, A.
    Cseuz, R.
    Nikulenkova, N.
    Glowacka-Kulesz, M.
    Szombati, I.
    Dudek, A.
    Mozaffarian, N.
    Greer, J.
    Kunder, R.
    An, D.
    Harrison, P.
    Van der Aa, A.
    Kavanaugh, A.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 961
  • [6] Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study
    Lauriello, John
    Claxton, Amy
    Du, Yangchun
    Weiden, Peter J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [7] Long-Term Neurocognitive Safety of LDL-C Lowering With Evolocumab: OpenLabel Extension Data From FOURIER
    Zimerman, Andre
    O'Donoghue, Michelle
    Ran, Xinhui
    Im, KyungAh
    Ott, Brian F.
    Mach, Francois
    Zavitz, Kenton
    Kurtz, Christopher E.
    Monsalvo, Maria L.
    Wang, Bei
    Atar, Dan
    Keech, Anthony
    Sabatine, Marc S.
    Giugliano, Robert
    [J]. CIRCULATION, 2023, 148
  • [8] SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY
    Gottenberg, J. E.
    Burmester, G. R.
    Van Beneden, K.
    Watson, C.
    Seghers, I.
    Rajendran, V.
    Dagna, L.
    Buch, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 512 - 513
  • [9] Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Caporali, Roberto
    Combe, Bernard
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    [J]. RHEUMATOLOGY, 2024, 63
  • [10] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis: Week 156 Results from a Long-term Extension Study
    Buch, Maya
    Aletaha, Daniel
    Caporali, Roberto F.
    Combe, Bernard G.
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4229 - 4231